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Adverse Drug Reactions: power, harm reduction, regulation
and the ADRe profile
Patients should be checked systematically to ensure that they are not being harmed by their
medication. Through case studies of prescriptions of antipsychotics to older adults in the UK, we
have shown that if healthcare professionals systematically checked, harm could be prevented.
Healthcare professionals often place too much faith in the medication they prescribe. Prescribed
medicines benefit between 4% and 25% of patients, but the harm caused by adverse drug
reactions (ADRs) can outweigh these benefits. For example, 11% of hospitalised patients
experience adverse effects from their medication, with 0.25% dying of ADRs. Up to 37% of patients
with cognitive impairment may experience similar kinds of harm. Yet healthcare systems have
failed to adopt standard procedures for checking for these harms, with many professionals finding it
difficult to distinguish the negative effects of medication from other forms of illness. This, in turn,
gives rise to more prescriptions, and more harm from medication.
Fig. 1. ADRe records and reports patients’ problems.
ADRs are a drain on healthcare resources, causing 5-8% of unplanned hospital admissions, rising
to 10% in older adults. This costs the UK’s National Health Service up to £1.6bn each year. Even
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this statistic may not represent the full problem: up to 60% of cases where patients are harmed by
their medicines go unrecognised and unreported. The introduction of a comprehensive and
systematic approach that bridges across healthcare professions would go a long way towards
addressing these preventable problems.
Our solution is the Adverse Drug Reaction (ADRe) Profile. It asks nurses to systematically check
patients for an itemised set of adverse or undesirable effects of their mental health medicines. It
also asks them to take action in case of problems, and, crucially, to share that information with
pharmacists or those prescribing medicines. It formalises and standardises the approach to
monitoring patients prescribed mental health medicines (Fig. 1).
The profile asks nurses to check vital signs, and all the signs and symptoms associated with
potential adverse side effects. Nurses then document observations, plus any changes ADRs (Fig.
2). ADRe also covers key areas of wellbeing affected by medicines, including diet, non-prescription
medicines, service user’s perspectives, and modifications to an individual’s care plan. Nurses
then pass this completed profile to pharmacists and prescribers, to inform reviews of individual
patients’ medication. The profile enables a deeper analysis of patients’ problems, and enables
medication to be changed to avoid harm to patients.
Fig. 2. The ADRe Profile
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We found clear benefits to this approach in our case studies and randomised controlled trials. The
ADRe Profile collects data on patient problems into a single document that prescribers can use to
review medication. Use led to alleviation of patients’ pain, falls, sedation, aggression and
confusion, and reduced doses of antipsychotics and sedatives. Our findings indicate that the ADRe
Profile works: it empowers nurses and carers through a transfer of useful, necessary, and practical
knowledge.
Prescribers’ lack of engagement with service users and reluctance to de-prescribe perpetuates the
social distancing, ’othering’, and control of service users. Health problems arising from prescribed
medication can be stigmatising and disempowering: antidepressants can cause agitation,
nervousness and anxiety, whilst antipsychotics can cause movement disorders and cognitive
impairment. Relying on medication to address the problems caused by medication only compounds
matters. It can lead to real harm, and places too much power in the hands of those prescribing. As
our trials of the ADRe Profile have shown, regulation at the clinical level is insufficient. Healthcare
systems need the comprehensive checking of adverse side effects from medicines that the ADRe
Profile provides; this leads to improved care and  understanding of the impact of ADRs.
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